Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Neuregulin3 affects cell development in the skin and mammary glands.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Recombinant keratin K31 makes damaged hair thicker, stronger, and straighter.

Microbial biosurfactants could be a safer and environmentally friendly alternative to chemical surfactants in cosmetics.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

K42 and K124 keratins are only found in horse hoof lamellae.

Carbon dots show promise for tissue repair and growth but need more research to solve current challenges.

New regenerative treatments for hair loss show promise but need more research for confirmation.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Calanthe orchids have medicinal potential and contain 265 chemical compounds, but are underexplored.

Androgen use may increase the risk of stroke, but more research is needed.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

Ultrasound can help deliver genes to cells to stimulate tissue regeneration and enhance hair growth, but more research is needed to perfect the method.

Most off-label drug prescriptions in Saudi Arabia are for adults with depression and diabetes.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

Cannabidiol shows promise as an effective treatment for acne.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

JAK inhibitors show promise for treating various skin diseases.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.